Closing The Books On Purdue – And US FDA’s Policies To Control Opioids
Executive Summary
A massive settlement of opioid litigation is intended to end the era of opioid marketing defined by OxyContin. It also like closes the books on efforts to rely on the US FDA to control the prescription abuse crisis.